Related Experiment Videos
Enhancing tolerance to cold exposure--how successful have we been?
1Department of Medical Physiology, University of Tromsø, Norway.
Summary
Protecting against hypothermia involves improving cold tolerance. Pharmacological enhancement of thermogenesis using ephedrine and methylxanthine shows promise for delaying hypothermia onset in humans.
Area of Science:
- Physiology
- Environmental Medicine
- Thermoregulation
Background:
- Accidental hypothermia is a significant risk at high latitudes, especially during cold water immersion.
- Current protection strategies focus on reducing heat loss through insulation.
- Alternative approaches aim to enhance the body's cold tolerance by modifying thermoregulatory responses.
Purpose of the Study:
- To review the effectiveness of various strategies for improving human cold tolerance.
- To identify promising methods for delaying the onset of hypothermia.
Main Methods:
- Review of existing literature on strategies to improve cold tolerance.
- Evaluation of thermal acclimation, physical exercise, dietary thermogenesis enhancement, pharmacological thermogenesis enhancement, and thermoregulatory set-point manipulation.
Main Results:
- None of the reviewed strategies have yielded universally adopted methods for routine use in improving cold tolerance.
- Pharmacological enhancement of cold thermogenesis demonstrated potential.
Conclusions:
- Pharmacological enhancement of cold thermogenesis, specifically using ephedrine combined with methylxanthine, is the most promising approach identified for delaying hypothermia.
- Further research into pharmacological interventions may lead to practical methods for cold exposure protection.